, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

down 16.55 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Buy with price target $15 by MLV & Co

Posted on: Tuesday,  Jan 29, 2013  8:25 AM ET by MLV & Co

MLV & Co rated Buy Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 01/29/2013, when the stock price was $7.43.
Since then, Keryx Biopharmaceuticals, Inc. has lost 16.55% as of 01/12/2016's recent price of $6.20.
If you would have followed this MLV & Co's recommendation on KERX, you would have lost 16.55% of your investment in 1078 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

MLV & Co is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2013 8:25 AM Buy
7.43 15.00
as of 12/13/2013
1 Week down  -4.54 %
1 Month down  -4.09 %
3 Months up  33.58 %
1 YTD up  63.79 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy